Astri Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 0 | 250 | 250 | 0 | 0 |
| Gross Profit | N/A | 250 | 250 | N/A | N/A |
| Operating Expenses | 7,639 | 5,712 | 7,202 | 6,919 | 7,761 |
| Operating Income | -7,639 | -5,462 | -6,952 | -6,919 | -7,761 |
| Interest Expense | 57 | 81 | 105 | 127 | 149 |
| Other Income | 44 | 46 | 40 | 72 | 34 |
| Pre-tax Income | -7,652 | -5,497 | -7,017 | -6,974 | -7,876 |
| Net Income Continuous | -7,652 | -5,497 | -7,017 | -6,974 | -7,876 |
| Net Income | $-7,652 | $-5,497 | $-7,017 | $-6,974 | $-7,876 |
| EPS Basic Total Ops | -17.28 | -13.32 | -18.60 | -19.20 | -24.60 |
| EPS Basic Continuous Ops | -17.29 | -13.12 | -18.66 | -19.19 | -24.75 |
| EPS Diluted Total Ops | -17.28 | -13.32 | -18.60 | -19.20 | -24.60 |
| EPS Diluted Continuous Ops | -17.29 | -13.12 | -18.66 | -19.19 | -24.75 |
| EBITDA(a) | $-7,577 | $-5,395 | $-6,880 | $-6,842 | $-7,673 |